Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study Protocol
1 other identifier
interventional
20
1 country
1
Brief Summary
Abstract Background Neuropathic pain is a common complication in neuromyelitis optica spectrum disorder (NMOSD), which seriously affects the quality of life of NMOSD patients, with no satisfactory treatment. Through the previous literature study and clinical observation, we found that acupuncture has good curative effect in the treatment of pain, especially electric acupuncture, but thestudies on acupuncture intervention in pain of NMOSD are still scare. Objective To evaluate the clinical efficacy of electroacupuncture on NMOSD patients with pain. Materials and Methods In this exploratory randomized controlled study, NMOSD patients with pain were recruited from March 21, 2022 to February 21, 2023. Patients meeting the inclusion and exclusion criteria were randomly assigned to the electroacupuncture group (experimental group) and the sham electroacupuncture group (control group) by simple random method (envelope method) according to the inclusion order. Totally, there are 20 patients enrolled. The experimental group received electroacupuncture therapy and the control group received sham electroacupuncture therapy. A total of 8 sessions were given twice a week for 30 minutes each. On the baseline, demographic information, medication history, specimens of routine blood, blood biochemistry, liver function, IL - 6, TNF-α were collected, the brain, cervical and thoracic MRI were perfected and collected, patients filled in the SF - MPQ, NRS, SF - 36, SAS, SDS, EDSS. After the treatment, specimens of routine blood, blood biochemistry, liver function, IL - 6, TNF-α were collected again, patients filled in the SF - MPQ, NRS, SF - 36, SAS, SD, EDSS. The main outcome indicators were SF-MPQ, and the secondary outcome indicators were EDSS, NRS, SAS, SDS, SF-36, IL-6, and TNF-α. Conclusion This is the first exploratory randomized controlled study to evaluate the efficacy of electroacupuncture on pain in patients with NMOSD. The study will provide clincial evidence of the practice of electroacupuncture on NMOSD with pain. Key Words neuromyelitis optica spectrum disorders; pain; electroacupuncture
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2023
CompletedFirst Submitted
Initial submission to the registry
April 20, 2023
CompletedFirst Posted
Study publicly available on registry
May 23, 2023
CompletedMay 23, 2023
May 1, 2023
11 months
April 20, 2023
May 20, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Short-Form of McGill Pain Questionnaire(SF - MPQ)
higher scores mean a worse outcome.
on the baseline
Short-Form of McGill Pain Questionnaire(SF - MPQ)
higher scores mean a worse outcome.
through study completion, an average of 1 month
Secondary Outcomes (14)
Expanded Disability Status Scale(EDSS)
on the baseline
Expanded Disability Status Scale(EDSS)
through study completion, an average of 1 month
numerical rating scale(NRS)
on the baseline
numerical rating scale(NRS)
through study completion, an average of 1 month
Self-Rating Anxiety Scale (SAS)
on the baseline
- +9 more secondary outcomes
Study Arms (2)
the electroacupuncture group
EXPERIMENTALelectroacupuncture were inserted into bilateral Zusanli (ST36), Sanyinjiao (SP6), Hegu (LI4) and Quchi (LI11), and Yintang (EX-HN3). Electroacupuncture parameters selected the sparse wave, the frequency was 4 Hz, the stimulation intensity was tolerated by the patient.
the sham electroacupuncture group
SHAM COMPARATORAccording to the previous trial,\[19\] sham acupoints were 1cm away from the level of the acupoints used in the EA group, which avoided the area corresponding to any of the 14 meridians of TCM. The insertion of the needle was shallower (less than 0.2cm) and had similar pain to that of normal needle insertion. The stimulation intensity was 0mA. However, the model of electroacupuncture, the frequency, and duration of treatment in the SEA group were identical in the TA group.
Interventions
electroacupuncture were inserted into bilateral Zusanli (ST36), Sanyinjiao (SP6), Hegu (LI4) and Quchi (LI11), and Yintang (EX-HN3). Electroacupuncture parameters selected the sparse wave, the frequency was 4 Hz, the stimulation intensity was tolerated by the patient.
Eligibility Criteria
You may qualify if:
- people diagnosed as NMOSD according to the International Panel for NMO Diagnosis (IPND) criteria.\[21\]
- NRS≥4.
- people were treated with stable doses of biological therapy and/or prednisone, with no regimen adjustment within 30 days prior to enrollment.
- people did not adjust any standard pain medication combinations, including antiepileptic drugs, antidepressants, and opioids, within 30 days before enrollment.
- people or their families provided written informed consent.
You may not qualify if:
- people enrolled in other clinical studies.
- people with low cognitive or mental ability.
- people who became pregnant during the study period, breastfed, or planned to become pregnant.
- people with serious diseases related to the heart, liver, kidney or hematopoietic system.
- people with diabetic peripheral neuropathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yuanqi Zhao,MDlead
Study Sites (1)
Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, Guangdong, 510000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Zhao yuan qi, Dr
Guangdong Provincial Hospital of Traditional Chinese Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- director
Study Record Dates
First Submitted
April 20, 2023
First Posted
May 23, 2023
Study Start
March 21, 2022
Primary Completion
February 21, 2023
Study Completion
February 21, 2023
Last Updated
May 23, 2023
Record last verified: 2023-05